Haisco Pharmaceutical Group Co., Ltd.
002653
Rank in Stocks
#2072
Haisco Pharmaceutical Group Co., Ltd., along with its subsidiaries, operates... Haisco Pharmaceutical Group Co., Ltd., along with its subsidiaries, operates within China, focusing on the research, production, and distribution of a diverse range of pharmaceutical products. Their offerings span various dosage forms, including small and large volume injections, freeze-dried and conventional powder injections, and active pharmaceutical ingredients (APIs). These medications target numerous therapeutic areas such as anti-infectives, digestive system disorders, blood system conditions, nervous system ailments, parenteral nutrition, antibiotics, emergency care, anesthesiology, and oncology. Furthermore, the company provides drugs in tablet, capsule, granule, and ointment forms for cardiovascular health, infectious diseases, digestive issues, central nervous system (CNS) conditions, diabetes, and hepatic diseases. Established in 2000 and based in Shannan, China, the company adopted its current name, Haisco Pharmaceutical Group Co., Ltd., in March 2016, having previously been known as Xizang Haisco Pharmaceutical Group Co., Ltd.
Share Price
$8.75
Market Cap
$9.99B
Change (1 day)
1.34%
Change (1 year)
20.35%
Country
CN
Trade Haisco Pharmaceutical Group Co., Ltd. (002653)
Category
Healthcare
Number of shares outstanding for Haisco Pharmaceutical Group Co., Ltd. (002653)
Number of shares outstanding as of June 2026: 1.12B
According to Haisco Pharmaceutical Group Co., Ltd. latest financial reports and stock price the company's current number of shares outstanding is 1.12B. At the end of December 2023 the company had 1.09B shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.
Shares outstanding history for Haisco Pharmaceutical Group Co., Ltd. (002653) from 2008 to 2026
Shares Outstanding at the end of each year
| Year | Shares Outstanding | Change |
|---|---|---|
| 2026 (TTM) | 1.12B | 0.00% |
| 2024 | 1.12B | 2.46% |
| 2023 | 1.09B | 1.62% |
| 2022 | 1.08B | -0.10% |
| 2021 | 1.08B | 0.66% |
| 2020 | 1.07B | 0.00% |
| 2019 | 1.07B | 0.00% |
| 2018 | 1.07B | 0.00% |
| 2017 | 1.07B | 0.00% |
| 2016 | 1.07B | 0.59% |
| 2015 | 1.06B | -0.88% |
| 2014 | 1.07B | -0.83% |
| 2013 | 1.08B | 0.10% |
| 2012 | 1.08B | 11.50% |
| 2011 | 969.19M | 2.14% |
| 2010 | 948.89M | 4.05% |
| 2009 | 911.96M | 0.42% |
| 2008 | 908.16M | 0.00% |
Shares Outstanding for similar companies or competitors
| Company | Shares Outstanding | Difference | Country |
|---|---|---|---|
| 253.90M | -77.33% |
US
|
|
| 396.00M | -64.64% |
US
|
|
| 478.91M | -57.24% |
AU
|
|
| - | - |
CH
|
|
| 62.19M | -94.45% |
NL
|
